Healthcare IBD - Summary & Resources
####WSO resources
[Healthcare Overview](https://www.wallstreetoasis.com/forums/healthcare…)
[Biotech Finance: From IB to VC / HF to Funded Startup (Part 1)](https://www.wallstreetoasis.com/forums/biotech-fi…)
[Biotech Finance: Valuation Methodologies And Modeling Considerations (Part 2)](https://www.wallstreetoasis.com/forums/biotech-fi…)
[Q&A: BB IBD Healthcare Analyst](https://www.wallstreetoasis.com/forums/q&a-bb-ibd…)
[Questions About Healthcare M&A](https://www.wallstreetoasis.com/forums/questions-…)
[Guide to Evaluate a Biotech Company](https://www.wallstreetoasis.com/forums/guide-to-e…)
####External resources (news and reports)
[FierceBiotech](https://www.fiercebiotech.com/)
[FiercePharma](https://www.fiercepharma.com/)
[Biospace](https://www.biospace.com/news/)
[WSJ Health](https://www.wsj.com/news/business/health-industry)
[Medscape](https://www.medscape.com/)
[Bain's Global Healthcare Private Equity and Corporate M&A reports][]
[Paul Keckley's weekly report](https://www.paulkeckley.com/the-keckley-report)
[Axios Vitals](https://www.axios.com/newsletters/axios-vitals)
Medical device industry:
[Fierce MedTech](https://www.fiercebiotech.com/medtech)
[MassDevice](https://www.massdevice.com/)
[Medical Device Manufacturers Association](https://www.medicaldevices.org/news/)
####Books
**- "The Pharmagellan Guide to Biotech Forecasting and Valuation"**
**- "Biotechnology Valuation", Karl Kleegan**: Chapter 3 is about the drug development process. You can also check Chapter 4 to learn how to build a disease model. However, read this book only if you already know valuation (DCF, comps), because the author uses quick-n-dirty or overly complex techniques that you shouldn't follow as an investment banker (he was an ER guy).
####Graphic on the industry
!PHARMA(https://www.wallstreetoasis.com/files/styles/w800…)
####Bonus videos
*How To Analyze a Clinical Trial:* not directly related to IB, but still interesting in order to understand how clinical trials work and the effect of their results on share price
[Part 1](
[Part 2](https://www.youtube.com/watch?v=A-hYVtCA06c)
[Part 3]()
[Part 4](https://www.youtube.com/watch?v=_aO5BhyEgXo)
Anything I should add?
**Thanks to TheFlyingKiwi(https://www.wallstreetoasis.com/user/423544)!**
[Bain's Global Healthcare Private Equity and Corporate M&A reports]: https://www.bain.com/insights/topics/global-healt…
[Medscape]: https://www.medscape.com/
Solid thread. +1 and following.
I'd add https://www.paulkeckley.com/the-keckley-report</a">Paul Keckley's weekly report to the ex resources. He does great political analysis and provides insight from government and survey data.
https://www.medscape.com/</a">Medscape
https://www.fiercebiotech.com/medtech</a">Fierce MedTech
https://www.massdevice.com/</a">Mass Device
WSJ Health
https://www.medicaldevices.org/news/</a">Med Dev Manufacturers Assoc (I just follow the Twitter account)
WSO:
https://www.wallstreetoasis.com/forums/biotech-finance-part-2-valuation…</a">Biotech Finance Part 2: Valuation Methodologies And Modeling Considerations
https://www.wallstreetoasis.com/forums/guide-to-evaluate-a-biotech-comp…</a">Guide To Evaluate A Biotech Company
Nice graphic on the industry.
Can't think of anymore off the top of my head. Looking forward to what others say as well.
I'm adding your links, thanks!
Cheers! Would be interested if other users follow any individual Twitter accounts that posts good insights/knowledge. Always hard to find those.
bump
bump
bump
bump
Bump
Bump
Bump
Bump
Bump
https://www.mobihealthnews.com/
I work in HCIT corporate right now and read a lot from this website as well as CB Insights Digital Health (very solid). Pretty sure HW or HL has a public report about HCIT companies in 2020 (fairly in depth, similar to CB Insights).
Associate exit opps?
bump
Bump
wondering if anyone has any good healthcare business books?
Bump
B
B
Deleniti voluptas aliquid est expedita architecto consequatur optio aut. Dolorum laudantium ab perspiciatis deserunt ut distinctio et. Sed eligendi modi dolorem at in. Et aut et id fuga sunt cupiditate eveniet.
Eligendi autem repellendus vel debitis porro. Corrupti sed similique sint quidem minus quis. Voluptatem omnis distinctio nihil. Nobis soluta doloribus quas molestiae rerum.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Pariatur in consequatur eum et enim. Quia optio voluptatem magnam eligendi omnis consequuntur aut. Expedita excepturi earum itaque ipsa qui. Facere eum molestias expedita rerum temporibus illum. Voluptatibus dolor quia qui est assumenda molestiae vel et. Omnis non ducimus laboriosam ratione perspiciatis debitis.